Mr. Justin Hanka reports

MINDBIO SHOWCASES WORLD FIRST VOICE AI INTOXICATION DETECTION TECHNOLOGY IN USA. TARGETS HEALTH DIAGNOSTICS MARKET WITH EXCITING NEW TECHNOLOGY

Mindbio Therapeutics Corp. has launched an extended showcase of its voice and artificial intelligence powered intoxication detection technology in the United States. The showcase comes as the company lists its common shares for trading on the OTCQB market.

The company has developed and commercialized a technology, activated by the voice and powered by AI, to predict intoxication. The company has amassed large amounts of data from drug and alcohol clinical trials, and has developed proprietary algorithms as the basis for its prediction technologies with remarkable accuracy for the detection of alcohol and hallucinogenic drugs.

The company intends to expand its intoxication detection technologies to detect other prohibited drugs that are difficult to detect particularly at scale and volume and require specialized equipment, with Mindbio's solution provided by a simple analysis of the voice.

The voice analytic solution being developed by Mindbio is a game changer for intoxication detection in workplace environments, particularly where drug and alcohol testing is mandated by regulators, such as the mining industry, aviation and construction, and where high-volume testing at scale for a variety of drugs and alcohol presents major challenges for management, is time consuming and expensive.

In a world first, Mindbio has developed an AI model that uses over 50 million data points to predict alcohol intoxication with remarkable accuracy, just by using the human voice. The technology goes further to estimate actual blood alcohol concentration levels in the successful 2025 launch of the booze AI app.

The company is developing an enterprise version and new platform-level technology for health prediction using the human voice, and is expanding its drug and alcohol intoxication technology for use in workplace environments, call centres, mental health and law enforcement, and the company hopes to make announcements about the progress of the new technology, new products and markets, and potential commercial applications, shortly.

The company's chief executive officer Justin Hanka said, "Our voice and AI powered intoxication detection technology is an exciting new non-invasive diagnostic tool that has broad implications for the detection of internal health, wellness and disease states."

About Mindbio Therapeutics Corp.

Mindbio is a biotechnology company headquartered in Vancouver, B.C., that, for several years, has been conducting drug and alcohol research and has created health prediction technologies using AI and machine learning. The company has expertise in using speech analytics as a prediction tool for drug and alcohol intoxication, and has created a world-first voice and AI powered prediction model for drug and alcohol intoxication for use in consumer and enterprise situations. The company is developing a comprehensive enterprise platform using voice and powered by AI for use in detecting drug and alcohol intoxication in workplaces, law enforcement, mental health and telehealth.

We seek Safe Harbor.